|
시장보고서
상품코드
2148312
연속 바이오공정 시장 : 제품별, 프로세스별, 조업 규모별, 용도별, 최종사용자별, 지역별Continuous Bioprocessing Market, By Product, By Process, By Scale of Operation, By Application, By End User, By Geography |
||||||
연속 바이오프로세싱 시장 규모는 2026년에 5억 1,240만 달러로 추정되며, 2033년까지 19억 9,130만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 21.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 5억 1,240만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 21.40% | 2033년 시장 규모 예측 : | 19억 9,130만 달러 |
전 세계 연속 바이오공정 시장은 바이오의약품의 기존 배치 제조 방식에서 연속적이고 통합적이며 효율적인 바이오의약품 생산 방식으로 진화한 것입니다. 전 세계 연속 바이오공정 시장은 퍼퓨전형 바이오리액터, 연속 크로마토그래피, 인라인 모니터링 등의 기술을 활용하여 단일클론 항체, 백신,재조합 단백질, 세포 및 유전자 치료제 등의 생물학적 제제를 제조하는 동시에, 공정의 일관성, 제품의 품질, 제조 공간 및 운영 효율을 향상시키는 것이 특징입니다.
바이오의약품에 대한 수요 증가와 바이오의약품 기업들이 생산 경제성 향상 및 시장 출시 기간 단축에 주력하고 있는 점도 이 기술 시장 도입을 뒷받침하고 있습니다. 또한, ‘품질 설계(QbD)’ 및 ‘공정 분석 기술(PAT)’에 관한 규제적 노력에 더해, 자동화 및 디지털 통합의 진전 또한 차세대 바이오의약품 생산의 중요한 요소로서 연속 제조로의 전환을 가속화하는 요인이 되고 있습니다.
시장 역학
전 세계 연속 바이오공정 시장은 단일클론 항체, 바이오시밀러, 백신, 세포 및 유전자 치료제 등 바이오의약품에 대한 수요 증가에 힘입어 성장하고 있습니다. 이는 제조업체들이 생산성 향상, 제조 원가 절감, 시설 면적 축소 및 공정 일관성 향상을 추구하고 있기 때문입니다. 규제 당국의 지원에 더해, 공정 분석 기술(PAT), 인공지능, 머신러닝 및 실시간 출하 시험의 통합이 바이오의약품 제조업체 전반에 걸친 도입을 더욱 촉진하고 있습니다.
그러나 배치 방식 인프라에서 전환하는 데 따르는 막대한 설비 투자, 공정 검증의 복잡성, 규제 측면의 불확실성, 숙련된 전문 인력 부족 등 시장에는 몇 가지 제약 요인이 존재합니다. 그럼에도 불구하고 바이오시밀러 분야, 특히 아시아태평양 및 라틴아메리카에서는 큰 기회가 존재하며, 맞춤형 의료, 모듈식 제조, 그리고 기술 제공업체, CDMO, 바이오의약품 기업 간의 전략적 제휴 역시 큰 비즈니스 기회를 가져다주고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설했습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략)를 바탕으로 전 세계 연속 바이오공정 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서에서 얻은 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 ‘세계 연속 바이오프로세싱 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 연속 바이오프로세싱 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 연속 바이오공정 시장 : 제품별, 2021년-2033년
제5장 세계의 연속 바이오공정 시장 : 프로세스별, 2021년-2033년
제6장 세계의 연속 바이오공정 시장 : 사업 스케일별, 2021년-2033년
제7장 세계의 연속 바이오공정 시장 : 용도별, 2021년-2033년
제8장 세계의 연속 바이오공정 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 연속 바이오공정 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.10.20Continuous Bioprocessing Market is estimated to be valued at USD 512.4 Mn in 2026 and is expected to reach USD 1,991.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 21.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 512.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 21.40% | 2033 Value Projection: | USD 1,991.3 Mn |
The global continuous bioprocessing market is an evolution of the traditional batch manufacturing of biopharmaceuticals to the continuous, integrated and efficient production of biopharmaceuticals. The global continuous bioprocessing market is characterized by the use of technologies such as perfusion bioreactors, continuous chromatography and inline monitoring to manufacture biologicals such as monoclonal antibodies, vaccines, recombinant proteins and cell and gene therapies, while enhancing the process consistency, product quality, manufacturing footprint and operational efficiency.
The increasing demand for biologics and the biopharmaceutical companies' focus on improving the economics of production and shortening the time-to-market are also driving the market adoption. Quality by Design (QbD) and Process Analytical Technology (PAT) regulatory initiatives, along with advances in automation and digital integration are also helping to accelerate the move toward continuous manufacturing as a significant part of next generation biopharmaceutical production.
Market Dynamics
The global continuous bioprocessing market is driven by the increasing demand for biologics such as monoclonal antibodies, biosimilars, vaccines and cell and gene therapies as manufacturers require higher productivity, lower cost of goods, smaller facility footprints and better process consistency. Regulatory support along with integration of Process Analytical Technology (PAT), artificial intelligence, machine learning and real-time release testing is further fueling adoption across biopharmaceutical manufacturers.
However, a number of constraints are present in the market, such as high capital requirements for migrating from batch-based infrastructure, complexity of process validation, regulatory uncertainty, and limited pool of skilled professionals. Nevertheless, significant opportunities exist in biosimilars, especially in Asia Pacific and Latin America, and presents considerable opportunities, as does individualized medicine, modular manufacturing and strategic alliances between technology providers, CDMOs and biopharmaceutical companies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global continuous bioprocessing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Repligen Corporation, Eppendorf SE, Getinge AB, 3M Company, Lonza Group Ltd., and Asahi Kasei Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global continuous bioprocessing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous bioprocessing market
Market Segmentation
- Product Insights (Revenue, USD Mn, 2021 - 2033)
- Continuous Bioreactors
- Continuous Chromatography Systems
- Continuous Filtration Systems
- Continuous Cell Culture Systems
- Continuous Media and Buffer Preparation Systems
- Continuous Virus Inactivation Systems
- Continuous Downstream Processing Systems
- Others
- Process Insights (Revenue, USD Mn, 2021 - 2033)
- Upstream Processing
- Downstream Processing
- Scale of Operation Insights (Revenue, USD Mn, 2021 - 2033)
- Small-Scale
- Medium-Scale
- Large-Scale
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Cell and Gene Therapies
- Blood and Plasma Products
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Danaher Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Repligen Corporation
- Eppendorf SE
- Getinge AB
- 3M Company
- Lonza Group Ltd.
- Asahi Kasei Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Continuous Bioprocessing Market, By Product
- Global Continuous Bioprocessing Market, By Process
- Global Continuous Bioprocessing Market, By Scale of Operation
- Global Continuous Bioprocessing Market, By Application
- Global Continuous Bioprocessing Market, By End User
- Global Continuous Bioprocessing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Continuous Bioprocessing Market, By Product, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Continuous Bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Chromatography Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Filtration Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Cell Culture Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Media and Buffer Preparation Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Virus Inactivation Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Downstream Processing Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Continuous Bioprocessing Market, By Process, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Upstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Downstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Continuous Bioprocessing Market, By Scale of Operation, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small-Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Medium-Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Large-Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Continuous Bioprocessing Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cell and Gene Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Blood and Plasma Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Continuous Bioprocessing Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Continuous Bioprocessing Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Repligen Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eppendorf SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
